The Directors have pleasure in presenting before you the 28th Boards' Report of the Company together with the
Audited Statements of Accounts for the year ended 31st March, 2024.

1. FINANCIAL SUMMARY/HIGHLIGHTS:

The performance during the period ended 31st March, 2024 has been as under:

CRs In I akhst

2. REVIEW OF OPERATIONS:

The total revenue of the Company for the financial year on standalone basis under review was nil as against
total revenue of Rs.30.69 lakhs for the previous financial year. The company incurred a net loss of Rs. 24.99
Lakhs for the financial year 2023-24 as against the net loss of Rs.70.57 Lakhs for the previous year.

The total revenue of the Company for the financial year on consolidated basis under review was nil as
against total revenue of Rs.30.69 lakhs for the previous financial year. The company incurred a net loss of
Rs. 24.99 Lakhs for the financial year 2023-24 as against a net loss of Rs. 70.57 Lakhs for the previous year.

3. DIVIDEND:

Your Directors have decided not to recommend any dividend for the year 2023-24.

4. BUSINESS UPDATE AND STATE OF COMPANY’S AFFAIRS:

The information on Company's affairs and related aspects is provided under Management Discussion and
Analysis report, which has been prepared, inter-alia, in compliance with Regulation 34 of SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 and forms part of this Report.

5. RESERVES:

The Closing balance of reserves, including retained earnings, of the Company as at March 31st, 2024 is
Rs.(2,46,55,000).

6. CHANGE IN THE NATURE OF BUSINESS, IF ANY:

During the period under review and the date of Board's Report there was no change in the nature of
Business.

7. MATERIAL CHANGES AND COMMITMENTS:

There were no material changes and commitments affecting financial position of the company between 31st
March and the date of Board's Report (i.e. 12.08.2024).

8. REVISION OF FINANCIAL STATEMENTS:

There was no revision of the financial statements for the year under review.

9. SHARE CAPITAL:

The authorized share capital of the Company stands at Rs.16,00,00,000/- divided into 1,60,00,000 equity
shares of Rs.10/- each.

The paid-up share capital of the Company stands at Rs.14,80,87,060/- divided into 1,48,08,706 equity
shares of Rs.10/- each.

10. UNPAID / UNCLAIMED DIVIDEND:

There is no unpaid or unclaimed dividend with the company till date.

11. INVESTOR EDUCATION AND PROTECTION FUND (IEPF):

Pursuant to the provisions of Section 124 of the Act, Investor Education and Protection Fund Authority
(Accounting, Audit, Transfer and Refund) Rules, 2016 (“IEPF Rules”) read with the relevant circulars and
amendments thereto, the amount of dividend remaining unpaid or unclaimed for a period of seven years
from the due date is required to be transferred to the Investor Education and Protection Fund (“IEPF”),
constituted by the Central Government.

During the Year, no amount of dividend was unpaid or unclaimed for a period of seven years and therefore
no amount is required to be transferred to Investor Education and Provident Fund under the Section 125(1)
and Section 125(2) of the Act.

12. DIRECTORS OR KMP APPOINTED OR RESIGNED:

Mrs. Annapantula Vydehi retires by rotation and being eligible, offers herself for re-appointment. A resolution
seeking shareholders' approval for her re-appointment along with other required details forms part of the
Notice.

Appointments:

Mr. Krishnam Raju Kalidindi (DIN: 00874650) was appointed as Whole-Time Director and Executive
Chairman w.e.f 27.12.2024 subject to the approval of the shareholders in the ensuing general meeting.

Mr. K.N.V. Narendra Kumar (DIN: 09223904) was appointed as Whole-Time Director and CFO w.e.f
02.07.2024, subject to the approval of the shareholders in the ensuing general meeting.

Resignation:

Ms. Aakansha resigned as an Independent Director of the Company w.e.f 02.09.2023.

13. DECLARATION FROM INDEPENDENT DIRECTORS ON ANNUAL BASIS:

The Company has received declarations from all the Independent Directors of the Company to the effect
that they are meeting the criteria of independence as provided in Sub-Section (7) of Section 149 of the
Companies Act, 2013 and Regulation 25 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015.The Independent Directors have also confirmed that they have complied with the
Company's Code of Conduct. In terms of Regulations 25(8) of the Listing Regulations, the Independent
Directors have confirmed that they are not aware of any circumstance or situation, which exists or may be
reasonably anticipated, that could impair or impact their ability to discharge their duties with an objective
independent judgment and without any external influence.

During the year, Independent Directors of the Company had no pecuniary relationship or transactions with
the Company, other than sitting fees, commission and reimbursement of expenses incurred by them for the
purpose of attending meetings of the Board of Directors and Committee(s).

14. BOARD MEETINGS:

The Board of Directors duly met Seven (7) times on 29.05.2023, 14.08.2023, 02.09.2023, 29.09.2023,
14.11.2023, 3.01.2024, and 31.01.2024 in respect of which meetings, proper notices were given and the
proceedings were properly recorded and signed in the Minutes Book maintained for the purpose.

15. BOARD EVALUATION:

Evaluation of all Board members is performed on an annual basis. The evaluation is performed by the
Board, Nomination and Remuneration Committee and Independent Directors with specific focus on the
performance and effective functioning of the Board and Individual Directors.

In line with Securities and Exchange Board of India Circular No. SEBI/HO/CFD/CMD/CIR/P/2017/004,
dated January 5, 2017 and the Companies Amendment Act, 2017 the Company adopted the recommended
criteria by Securities and Exchange Board of India.

The criteria for performance evaluation covers the areas relevant to the functioning of the Board and Board
Committees such as its composition, oversight and effectiveness, performance, skills and structure etc.

The evaluation of Board of Directors is performed by the Board after seeking all the inputs from the Directors
and the Board Committees by seeking inputs from the Committee members.

The performance evaluation of the individual directors is done by the Nomination and Remuneration
Committee.

The performance evaluation of non-independent directors, the Board as a whole and the Chairman is done
by a separate meeting of Independent directors after taking inputs from the Executive directors.

16. STATEMENT SHOWING THE NAMES OF THE TOP TEN EMPLOYEES IN TERMS OF REMUNERATION
DRAWN AND THE NAME OF EVERY EMPLOYEE AS PER RULE 5(2) & (3) OF THE COMPANIES
(APPOINTMENT & REMUNERATION) RULES, 2014:

Disclosure pertaining to remuneration and other details as required under section 197 of the Companies
Act, 2013 read with rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel)
Rules, 2014 is given in Annexure 1 to this Report.

The Statement containing the particulars of employees as required under section 197(12) of the Companies
Act, 2013 read with rule 5(2) and other applicable rules (if any) of the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014, is provided in Annexure 2 to this report.

During the year, NONE of the employees is drawing a remuneration of Rs.1,02,00,000/- and above per
annum or Rs.8,50,000/- and above in aggregate per month, the limits specified under the Section 197(12) of
the Companies Act, 2013 read with Rules 5(2) and 5(3) of the Companies (Appointment and Remuneration
of Managerial Personnel) Rules, 2014.

17. RATIO OF REMUNERATION TO EACH DIRECTOR:

Under section 197(12) of the Companies Act, 2013, and Rule 5(1) (2) & (3) of the Companies (Appointment
& Remuneration) Rules, 2014 read with Schedule V of the Companies Act, 2013 the ratio of remuneration of
(Mr. K.N.V. Narendra Kumar), Whole-time director of the Company to the median remuneration of the
employee is 1.52:1. Mr. K. Krishnam Raju is not drawing any remuneration from the Company.

18. DIRECTOR’S RESPONSIBILITY STATEMENT:

Pursuant to Section 134(5) of the Companies Act, 2013, the Board of Directors, to the best of their
knowledge and ability, confirm that:

(a) In the preparation of the annual accounts, the applicable accounting standards had been followed along
with proper explanation relating to material departures;

(b) The Directors had selected such accounting policies and applied them consistently and made judgments
and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the
company at the end of the financial year and of the profit and loss of the company for that period;

(c) The Directors had taken proper and sufficient care for the maintenance of adequate accounting records in
accordance with the provisions of this Act for safeguarding the assets of the company and for preventing
and detecting fraud and other irregularities;

(d) The Directors had prepared the annual accounts on a going concern basis; and

(e) The Directors had laid down internal financial controls to be followed by the company and that such internal
financial controls are adequate and were operating effectively.

(f) The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws
and that such systems were adequate and operating effectively.

19. DETAILS OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS:

The Internal Financial Controls with reference to financial statements as designed and implemented by the
Company are adequate. The Company maintains appropriate system of internal control, including
monitoring procedures, to ensure that all assets are safeguarded against loss from unauthorized use or
disposition. Company policies, guidelines and procedures provide for adequate checks and balances, and
are meant to ensure that all transactions are authorized, recorded and reported correctly.

During the period under review, there is no material or serious observations have been noticed for
inefficiency or inadequacy of such controls.

Further, details of internal financial control and its adequacy are included in the Management Discussion
and Analysis Report which is appended as Annexure 6 and forms part of this Report.

20. DETAILS IN RESPECT OF FRAUDS REPORTED BY AUDITORS UNDER SUB SECTION (12) OF
SECTION 143 OTHER THAN THOSE WHICH ARE REPORTABLE TO THE CENTRAL GOVERNMENT:

There have been no frauds reported by the auditors u/s 143(12).

21. CEO/ CFO CERTIFICATION:

The Whole-time Director and Chief Financial Officer Certification on the financial statements under
regulation 17 (8) of SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015 for the year
2023-2024 is annexed in this Annual Report.

22. INFORMATION ABOUT THE FINANCIAL PERFORMANCE / FINANCIAL POSITION OF THE
SUBSIDIARIES / ASSOCIATES/ JOINT VENTURES:

The company has no subsidiary and joint venture companies but has one Associate Company, Krisani Bio
Sciences Private Limited.

As per the provisions of Section 129 of the Companies Act, 2013 read with Companies (Accounts) Rules,
2014, a separate statement containing the salient features of the financial statements of the associate
company is prepared in Form AOC-1 and is attached as Annexure 3 and forms part of this report.

Status of Legal cases:

During the financial year 2023-24, Krisani Bio Sciences Pvt Ltd and its Promoter Director, Mr. K Krishnam
Raju had filed a complaint and registered FIR against Mr. Mahesh Kandula, Cellix Bio Pvt Ltd and its
directors and its subsidiary company (Avaca Pharma Private Limited) on the grounds of Criminal Breach of
Trust, Criminal Misappropriation of Property, Theft and Fraud on 3rd August, 2023. During the Financial
Year, Mr. Mahesh Kandula filed a petition in Hon'ble NCLT against Krisani Bio Sciences Pvt Ltd, Mr. K
Krishnam Raju, Samsrita Labs Limited and others. Mr. K. Krishnam Raju being a Promoter Director and
major Shareholder in Krisani Bio Sciences Private limited also filed on behalf of himself and other
shareholders of Krisani Bio Sciences Pvt Ltd in Hon'ble NCLT against Mr. Mahesh Kandula, Cellix Bio and
its directors and others. All the filed cases are in at different stages in Hon'ble Courts and Hon'ble NCLT.

23. DETAILS OF DEPOSITS NOT IN COMPLIANCE WITH THE REQUIREMENTS OF THE ACT:

Since the Company has not accepted any deposits during the Financial Year ended March 31,2024, there
has been no non-compliance with the requirements of the Act.

Pursuant to the Ministry of Corporate Affairs (MCA) notification dated 22nd January 2019 amending the
Companies (Acceptance of Deposits) Rules, 2014, the Company is required to file with the Registrar of
Companies (ROC) requisite returns in Form DPT-3 for outstanding receipt of money/loan by the Company,
which is not considered as deposits.

The Company complied with this requirement within the prescribed timelines.

24. PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS:

The Company has not given any loan, guarantees or made any investments attracting the provisions as
prescribed in Section 186 of the Companies Act, 2013.

25. RELATED PARTY TRANSACTIONS:

All related party transactions that were entered into during the financial year were on arm's length basis and
were in the ordinary course of business. During the financial year 2023-24, there were no materially
significant related party transactions made by the Company with Promoters, Directors, Key Managerial
Personnel or other designated persons which may have a potential conflict with the interest of the Company
at large.

In line with the provisions of Section 177 of the Act read with the Companies (Meetings of the Board and its
Powers) Rules, 2014, omnibus approval for the estimated value of transactions with the related parties for
the financial year is obtained from the Audit Committee. The transactions with the related parties are routine
and repetitive in nature.

The summary statement of transactions entered into with the related parties pursuant to the omnibus
approval so granted are reviewed and approved by the Audit Committee and the Board of Directors on a
quarterly basis. The summary statements are supported by an independent audit report certifying that the
transactions are at an arm's length basis and in the ordinary course of business.

The Form AOC-2 pursuant to Section 134(3) (h) of the Companies Act, 2013 read with Rule 8(2) of the
Companies (Accounts) Rules, 2014 is annexed herewith as Annexure 4 to this report.

26. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE OUTGO:

The required information as per Sec.134 (3) (m) of the Companies Act 2013 is provided hereunder:

A. Conservation of Energy: Your Company's operations are not energy intensive. Adequate measures have
been taken to conserve energy wherever possible by using energy efficient computers and purchase of
energy efficient equipment

B. Research & Development and Technology Absorption: All the Factors mentioned in Rule 8 (3) (b)
Technology absorption are not applicable to the Company.

1. Research and Development (R&D): NIL

2. Technology absorption, adoption and innovation: NIL

C. Foreign Exchange Earnings and Out Go:

1. Foreign Exchange Earnings: NIL

2. Foreign Exchange Outgo: NIL

27. COMMITTEES:

(I) . AUDIT COMMITTEE: The Audit Committee of the Company is constituted in line with the provisions of

Regulation 18(1) of SEBI (LODR) Regulations with the Stock Exchanges read with Section 177 of the
Companies Act, 2013 are included in the Corporate Governance report, which forms part of this report.

(II) . NOMINATION AND REMUNERATION COMMITTEE: The Nomination and Remuneration Committee of

the Company is constituted in line with the provisions of Regulation 19(1) of SEBI (LODR) Regulations with
the Stock Exchanges read with Section 178 of the Companies Act, 2013 are included in the Corporate
Governance report, which forms part of this report.

(III) . STAKEHOLDERS RELATIONSHIP COMMITTEE: The Stakeholders Relationship Committee of the

Company is constituted in line with the provisions of Regulation 20 of SEBI (LODR) Regulations with the
Stock Exchanges read with Section 178 of the Companies Act, 2013 are included in the Corporate
Governance report, which forms part of this report.

28. COMPOSITION OF CSR COMMITTEE AND CONTENTS OF CSR POLICY:

Since the Company does not have the net worth of Rs.500 Crore or more, or turnover of Rs.1000 Crore or
more, or a net profit of Rs.5 Crore or more during the financial year, section 135 of the Companies Act, 2013
relating to Corporate Social Responsibility is not applicable and hence the Company need not adopt any
Corporate Social Responsibility Policy.

29. VIGIL MECHANISM/WHISTLE BLOWER POLICY:

The Board of Directors has formulated a Whistle Blower Policy which is in compliance with the provisions of
Section 177(10) of the Companies Act, 2013 and Regulation 22 of the Listing Regulations. The Company
promotes ethical behavior and has put in place a mechanism for reporting illegal or unethical behavior. The
Company has a Vigil Mechanism and Whistle-blower policy under which the employees are free to report
violations of applicable laws and regulations and the Code of Conduct. Employees may report their genuine
concerns to the Chairman of the Audit Committee. During the year under review, no employee was denied
access to the Audit Committee.

Vigil Mechanism Policy has been established by the Company for directors and employees to report
genuine concerns pursuant to the provisions of section 177(9) & (10) of the Companies Act, 2013. The same
has been placed on the website of the Company https://drhlsl.com/investor/corporate-governance/.

30. SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS

There are no significant and material orders passed by the regulators /courts that would impact the going
concern status of the Company and its future operations.

31. STATUTORY AUDITORS AND STATUTORY AUDITORS REPORT:

• At the Board Meeting held on 02.09.2023, M/s. A.M. Reddy & D. R. Reddy., resigned as Statutory Auditors of
the Company causing Casual Vacancy.

• The Board of Directors in its meeting held on 02.09.2023 appointed M/s. N. G RAO & Associates, Chartered
Accountants as the Statutory Auditors of the Company till the conclusion of 27th Annual General Meeting to
fill the above casual vacancy.

• However, at the 27th Annual General Meeting held on 28.09.2023, the members of the company have not
approved the proposal of appointment of M/s. N. G RAO & Associates, Chartered Accountants as the
Statutory Auditors of the Company.

• Further, the Board of Directors in its Meeting held on 29.09.2023 approved the appointment of M/s. MGR &
Co., Chartered Accountants as Statutory Auditors of the Company upto the EGM held on 31.10.2023.

• Accordingly, at the Extra- Ordinary General Meeting held on 31.10.2023, the members of the company
approved the appointment of M/s. Mgr & Co, Chartered Accountants as Statutory Auditors of the company
until the conclusion of forthcoming 28th Annual General Meeting for the financial year 2023-24.

The Auditors' Report for fiscal 2024 does not contain any qualification, reservation or adverse remark. The
Auditors' Report is enclosed with the financial statements in this Annual Report. The Company has received
audit report with unmodified opinion for on basis of audited financial results of the Company for the Financial
Year ended March 31,2024 from the statutory auditors of the Company.

The Auditors have confirmed that they have subjected themselves to the peer review process of Institute of
Chartered Accountants of India (ICAI) and hold valid certificate issued by the Peer Review Board of the ICAI.

32. ANNUAL SECRETARIAL COMPLIANCE REPORT:

SEBI vide its Circular No. CIR/CFD/CMD1/27/2019 dated February 08, 2019 read with Regulation 24(A) of
the Listing Regulations, directed listed entities to conduct Annual Secretarial compliance audit from a
Practicing Company Secretary of all applicable SEBI Regulations and circulars/guidelines issued
thereunder. Further, Secretarial Compliance Report dated 27.05.2024, was given by M/s. S.S. Reddy &
Associates, Practicing Company Secretary which was submitted to Stock Exchanges within 60 days of the
end of the financial year.

33. SECRETARIAL AUDIT REPORT:

In terms of section 204 of the Companies Act, 2013 read with the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014, based upon the recommendations of the Audit
Committee, the Board of Directors had appointed M/s. S.S. Reddy & Associates, Practicing Company
Secretaries (CP No. 7478) as the Secretarial Auditor of the Company, for conducting the Secretarial Audit
for financial year ended March 31,2024.

The Secretarial Audit was carried out by M/s. S.S. Reddy & Associates, Company Secretaries (CP No.
7478) for the financial year ended March 31,2024. The Report given by the Secretarial Auditor is annexed
herewith as Annexure- 5 and forms integral part of this Report.

The observations in the Secretarial Audit Report are self-explanatory and do not require any comments
thereon.

34. INTERNAL AUDITORS:

Pursuant to provisions of Section 138 read with Rule 13 of the Companies (Accounts) Rules, 2014 and
Section 179 read with Rule 8(4) of the Companies (Meetings of Board and its Powers) Rules, 2014; during
the year under review the Internal Audit of the functions and activities of the Company was undertaken by
the Internal Auditor of the Company on quarterly basis by M/s. Tungala & Co., Chartered Accountants., the
Internal Auditors of the Company.

Deviations are reviewed periodically and due compliance ensured. Summary of Significant Audit
Observations along with recommendations and its implementations are reviewed by the Audit Committee
and concerns, if any, are reported to Board. There were no adverse remarks or qualification on accounts of
the Company from the Internal Auditor.

35. SECRETARIAL STANDARDS:

The Company is in compliance with the applicable secretarial standards.

36. DECLARATION BY THE COMPANY:

The Company has issued a certificate to its Directors, confirming that it has not made any default under
Section 164(2) of the Companies Act, 2013, as on March 31,2024.

37. ANNUAL RETURN:

As required pursuant to section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies
(Management and Administration) Rules, 2014, an annual return is uploaded on website of the Company
https://drhlsl.com/investor/annual-return/.

38. DISCLOSURE ABOUT COST AUDIT:

Maintenance of cost records and requirement of cost audit as prescribed under the provisions of Section
148(1) of the Act, are not applicable for the business activities carried out by the Company.

39. MANAGEMENT DISCUSSION AND ANALYSIS REPORT:

The Management Discussion and Analysis Report, pursuant to the SEBI (LODR) Regulation provides an
overview of the affairs of the Company, its legal status and autonomy, business environment, mission &
objectives, sectoral and operational performance, strengths, opportunities, constraints, strategy and risks
and concerns, as well as human resource and internal control systems is appended as Annexure 6 for
information of the Members.

40. FAMILIARISATION PROGRAMMES FOR INDEPENDENT DIRECTORS:

The Company familiarises its Independent Directors on their appointment as such on the Board with the
Company, their roles, rights, responsibilities in the Company, nature of the industry in which the Company
operates, etc. through familiarisation programme. The Company also conducts orientation programme
upon induction of new Directors, as well as other initiatives to update the Directors on a continuing basis.
The familiarisation programme for Independent Directors is disclosed on the Company's website
www.drhlsl.com.

41. INSURANCE:

The Company is not having any major fixed asset and therefore no insurance is taken.

42. CORPORATE GOVERNANCE AND SHAREHOLDERS INFORMATION:

The Company has implemented all of its major stipulations as applicable to the Company. As stipulated
under Regulation 34 read with schedule V of SEBI (LODR) Regulations, 2015, a report on Corporate
Governance duly audited is appended as Annexure 7 for information of the Members. A requisite certificate
from the Secretarial Auditors of the Company confirming compliance with the conditions of Corporate
Governance is attached to the Report on Corporate Governance.

43. NON-EXECUTIVE DIRECTORS’ COMPENSATION AND DISCLOSURES:

None of the Independent / Non-Executive Directors has any pecuniary relationship or transactions with the
Company which in the Judgment of the Board may affect the independence of the Directors.

No compensation was paid to the Independent and Non-Executive Directors.

44. COMPANY’S POLICY ON DIRECTORS’ APPOINTMENT AND REMUNERATION INCLUDING
CRITERIA FOR DETERMINING QUALIFICATIONS, POSITIVE ATTRIBUTES, INDEPENDENCE OF A
DIRECTOR AND OTHER MATTERS PROVIDED UNDER SUB-SECTION (3) OF SECTION 178:

The assessment and appointment of Members to the Board is based on a combination of criterion that
includes ethics, personal and professional stature, domain expertise, gender diversity and specific
qualification required for the position. The potential Board Member is also assessed on the basis of
independence criteria defined in Section 149(6) of the Companies Act, 2013 and Regulation 27 of SEBI
(LODR) Regulations, 2015. In accordance with Section 178(3) of the Companies Act, 2013 and Regulation
19(4) of SEBI (LODR) Regulations, 2015, on the recommendations of the Nomination and Remuneration
Committee, the Board adopted a remuneration policy for Directors, Key Management Personnel (KMPs)
and Senior Management. The Policy is attached a part of Corporate Governance Report. We affirm that the
remuneration paid to the Directors is as per the terms laid down in the Nomination and Remuneration Policy
of the Company.

45. CODE OF CONDUCT FOR THE PREVENTION OF INSIDER TRADING:

The Board of Directors has adopted the Insider Trading Policy in accordance with the requirements of the
SEBI (Prohibition of Insider Trading) Regulation, 2015 and the applicable Securities laws. The Insider
Trading Policy of the Company lays down guidelines and procedures to be followed, and disclosures to be
made while dealing with shares of the Company, as well as the consequences of violation. The policy has
been formulated to regulate, monitor and ensure reporting of deals by employees and to maintain the
highest ethical standards of dealing in Company securities.

The Insider Trading Policy of the Company covering code of practices and procedures for fair disclosure of
unpublished price sensitive information and code of conduct for the prevention of insider trading is available
on our website https://drhlsl.com/investor/corporate-governance/.

46. DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION,
PROHIBITION AND REDRESSAL) ACT, 2013:

The Company has in place an Anti-Sexual Harassment Policy in line with the requirements of The Sexual
Harassment of Women at workplace (Prevention, Prohibition and Redressal) Act, 2013. Internal Committee
(IC) has not been constituted since there are less than 10 employees in the Company.

During the year 2023-24, there were no complaints received by the Company.

47. INDUSTRY BASED DISCLOSURES AS MANDATED BY THE RESPECTIVE LAWS GOVERNING THE
COMPANY:

The Company is not a NBFC, Housing Companies etc., and hence Industry based disclosures is not
required.

48. FAILURE TO IMPLEMENT CORPORATE ACTIONS:

During the year under review, no corporate actions were done by the Company which were failed to be
implemented.

49. DETAILS OF APPLICATION MADE OR PROCEEDING PENDING UNDER INSOLVENCY AND
BANKRUPTCY CODE, 2016:

During the year under review, there were no applications made or proceedings pending in the name of the
Company under Insolvency and Bankruptcy Code, 2016.

50. DETAILS OF DIFFERENCE BETWEEN VALUATION AMOUNT ON ONE TIME SETTLEMENT AND
VALUATION WHILE AVAILING LOAN FROM BANKS AND FINANCIAL INSTITUTIONS:

During the year under review, there has been no one-time settlement of loans taken from banks and
financial institutions.

51. POLICIES:

The SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 mandated the formulation
of certain policies for all listed companies. All the policies are available on our website
https://drhlsl.com/investor/corporate-governance/.

52. EVENT BASED DISCLOSURES:

During the year under review, the Company has not taken up any of the following activities except as
mentioned:

1. Issue of sweat equity share: NA

2. Issue of shares with differential rights: NA

3. Issue of shares under employee's stock option scheme: NA

4. Disclosure on purchase by Company or giving of loans by it for purchase of its shares: NA

5. Buy back shares: NA

6. Disclosure about revision: NA

7. Preferential Allotment of Shares: NA

53. INTERNAL AUDIT AND FINANCIAL CONTROLS:

The Company has adequate internal controls consistent with the nature of business and size of the
operations, to effectively provide for safety of its assets, reliability of financial transactions with adequate
checks and balances, adherence to applicable statues, accounting policies, approval procedures and to
ensure optimum use of available resources. These systems are reviewed and improved on a regular basis.
It has a comprehensive budgetary control system to monitor revenue and expenditure against approved
budget on an ongoing basis.

54. CONSOLIDATED FINANCIAL STATEMENTS:

The company does not have any subsidiary at the end of financial year under the review. However, it is
having an associate company and in compliance with the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (hereinafter referred to as the ‘Listing Regulations') and Section 129 of
the Companies Act, 2013, the Consolidated Financial Statements have been prepared by the Company in
accordance with the applicable provisions of the Companies Act, 2013 and the applicable Indian Accounting
Standards (Ind AS) and forms part of this Annual Report.

55. NAMES OF THE COMPANIES WHICH HAVE BECOME OR CEASED TO BE ITS SUBSIDIARIES, JOINT
VENTURES OR ASSOCIATE COMPANIES DURING THE YEAR:

There have been no companies which have become the subsidiaries, joint ventures and associates during
the year under review.

56. DETAILS RELATING TO DEPOSITS, COVERING THE FOLLOWING:

The Company has not accepted any public deposits during the Financial Year ended March 31,2024 and as
such, no amount of principal or interest on public deposits was outstanding as on the date of the balance
sheet.

57. CREDIT & GUARANTEE FACILITIES:

The Company has not availed credit and guarantee facilities.

58. RISK MANAGEMENT POLICY:

Business Risk Evaluation and Management is an ongoing process within the Organization. The Company
has a robust risk management framework to identify, monitor and minimize risks and also to identify
business opportunities. As a process, the risks associated with the business are identified and prioritized
based on severity, likelihood and effectiveness of current detection. Such risks are reviewed by the senior
management on a quarterly basis. Risk Management Committee of the Board of Directors of your Company
assists the Board in (a) overseeing and approving the Company's enterprise wide risk management
framework; and (b) overseeing that all the risks that the organization faces such as strategic, financial,
credit, market, liquidity, security, property, IT, legal, regulatory, reputational, other risks have been identified
and assessed, and there is an adequate risk management infrastructure in place capable of addressing
those risks. The development and implementation of risk management policy has been covered in the
Management Discussion and Analysis, which forms part of this Report.

59. ENVIRONMENTS AND HUMAN RESOURCE DEVELOPMENT:

Your Company always believes in keeping the environment pollution free and is fully committed to its social
responsibility. The Company has been taking upmost care in complying with all pollution control measures
from time to time strictly as per the directions of the Government.

We would like to place on record our appreciation for the efforts made by the management and the keen
interest shown by the Employees of your Company in this regard.

60. STATUTORY COMPLIANCE:

The Company has complied with the required provisions relating to statutory compliance with regard to the
affairs of the Company in all respects.

61. DEVIATIONS, IF ANY OBSERVED ON FUNDS RAISED THROUGH PUBLIC ISSUE, PREFERENTIAL
ISSUE ETC:

During the year under review, company has not raised any funds from public or through preferential
allotment.

62. ACKNOWLEDGEMENTS:

Your Directors place on record their appreciation for the co-operation and assistance received from the
investors, customers, business associates, bankers, vendors, as well as regulatory and governmental
authorities. Your Directors also thanks the employees at all levels, who through their dedication, co¬
operation, support and smart work have enabled the company to achieve a moderate growth and is
determined to poise a rapid and remarkable growth in the year to come.

Your Directors also wish to place on record their appreciation of business constituents, banks and other
financial institutions and shareholders of the Company, SEBI, BSE, MSEI, NSDL, CDSL, Banks, RBI,
Government of Telangana, Government of India etc. for their continued support for the growth of the
Company.

For and on behalf of the Board of
Samsrita Labs Limited

(Formerly known as Dr Habeebullah Life Sciences Limited)

Sd/-

K. Krishnam Raju

Place: Hyderabad Executive Chairman & Whole-Time Director

Date: 12.08.2024 (DIN: 00874650)